APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Canine Vaccine Market Outlook and Growth Opportunities 2026

26 December 2025197 pages

Choose your research edition.

Industry ResearchCanine Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Vaccine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Canine Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Canine Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canine Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Canine Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Canine Vaccine market include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Canine Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Canine Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Canine Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Canine Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Canine Vaccine Segment by Company

Biogenesis Bago

Boehringer Ingelheim

Durvet

NeoTech

Virbac

Pfizer

Jilin Five-Star Animal Health

JINHE

Wuhan Keqian Biology

SINOVAC

Elanco

Merck Animal Health

RuiPu Bio-Technology

Zoetis

CAHIC

Canine Vaccine Segment by Type

Core Vaccines

Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies

Adult Dogs

Canine Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Canine Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Canine Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Canine Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Canine Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canine Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Canine Vaccine industry.

Chapter 3: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Canine Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Canine Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Canine Vaccine Industry Trends Table 2. Canine Vaccine Industry Drivers Table 3. Canine Vaccine Industry Opportunities and Challenges Table 4. Canine Vaccine Industry Restraints Table 5. Global Canine Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Canine Vaccine Revenue Share by Company (2021-2026) Table 7. Global Canine Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Canine Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Canine Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Canine Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Canine Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Canine Vaccine Company, Product Type & Application Table 13. Global Canine Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Canine Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Core Vaccines Table 18. Significant Companies of Non-Core Vaccines Table 19. Global Canine Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Canine Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Canine Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Canine Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Canine Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Canine Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Canine Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Canine Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Canine Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Canine Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Puppies Table 30. Significant Companies of Adult Dogs Table 31. Global Canine Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Canine Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Canine Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Canine Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Canine Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Canine Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Canine Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Canine Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Canine Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Canine Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Canine Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Canine Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Canine Vaccine Sales by Region (2027-2032) & (K Units) Table 45. Global Canine Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Canine Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Canine Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Canine Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Canine Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Canine Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Canine Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Canine Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Canine Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 56. Global Canine Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Canine Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Canine Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Canine Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Canine Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Canine Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Biogenesis Bago Company Information Table 64. Biogenesis Bago Business Overview Table 65. Biogenesis Bago Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Biogenesis Bago Canine Vaccine Product Portfolio Table 67. Biogenesis Bago Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Canine Vaccine Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Durvet Company Information Table 74. Durvet Business Overview Table 75. Durvet Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Durvet Canine Vaccine Product Portfolio Table 77. Durvet Recent Development Table 78. NeoTech Company Information Table 79. NeoTech Business Overview Table 80. NeoTech Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. NeoTech Canine Vaccine Product Portfolio Table 82. NeoTech Recent Development Table 83. Virbac Company Information Table 84. Virbac Business Overview Table 85. Virbac Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Virbac Canine Vaccine Product Portfolio Table 87. Virbac Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer Canine Vaccine Product Portfolio Table 92. Pfizer Recent Development Table 93. Jilin Five-Star Animal Health Company Information Table 94. Jilin Five-Star Animal Health Business Overview Table 95. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Jilin Five-Star Animal Health Canine Vaccine Product Portfolio Table 97. Jilin Five-Star Animal Health Recent Development Table 98. JINHE Company Information Table 99. JINHE Business Overview Table 100. JINHE Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. JINHE Canine Vaccine Product Portfolio Table 102. JINHE Recent Development Table 103. Wuhan Keqian Biology Company Information Table 104. Wuhan Keqian Biology Business Overview Table 105. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Wuhan Keqian Biology Canine Vaccine Product Portfolio Table 107. Wuhan Keqian Biology Recent Development Table 108. SINOVAC Company Information Table 109. SINOVAC Business Overview Table 110. SINOVAC Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. SINOVAC Canine Vaccine Product Portfolio Table 112. SINOVAC Recent Development Table 113. Elanco Company Information Table 114. Elanco Business Overview Table 115. Elanco Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Elanco Canine Vaccine Product Portfolio Table 117. Elanco Recent Development Table 118. Merck Animal Health Company Information Table 119. Merck Animal Health Business Overview Table 120. Merck Animal Health Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Merck Animal Health Canine Vaccine Product Portfolio Table 122. Merck Animal Health Recent Development Table 123. RuiPu Bio-Technology Company Information Table 124. RuiPu Bio-Technology Business Overview Table 125. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. RuiPu Bio-Technology Canine Vaccine Product Portfolio Table 127. RuiPu Bio-Technology Recent Development Table 128. Zoetis Company Information Table 129. Zoetis Business Overview Table 130. Zoetis Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Zoetis Canine Vaccine Product Portfolio Table 132. Zoetis Recent Development Table 133. CAHIC Company Information Table 134. CAHIC Business Overview Table 135. CAHIC Canine Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. CAHIC Canine Vaccine Product Portfolio Table 137. CAHIC Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Canine Vaccine Distributors List Table 141. Canine Vaccine Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Canine Vaccine Product Image Figure 2. Global Canine Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Canine Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Canine Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Canine Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Core Vaccines Image Figure 10. Non-Core Vaccines Image Figure 11. Global Canine Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Canine Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Canine Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Canine Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Canine Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Canine Vaccine Sales Value Share by Type (2021-2032) Figure 17. Puppies Image Figure 18. Adult Dogs Image Figure 19. Global Canine Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Canine Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Canine Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Canine Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Canine Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Canine Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Canine Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Canine Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Canine Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Canine Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Canine Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Canine Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Canine Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Canine Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Canine Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Canine Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Canine Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Canine Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Canine Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Canine Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Canine Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Canine Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Canine Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Canine Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Core Vaccines
  • Non-Core Vaccines
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Durvet
  • NeoTech
  • Virbac
  • Pfizer
  • Jilin Five-Star Animal Health
  • JINHE
  • Wuhan Keqian Biology
  • SINOVAC
  • Elanco
  • Merck Animal Health
  • RuiPu Bio-Technology
  • Zoetis
  • CAHIC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Canine Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Canine Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Canine Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Canine Vaccine Market Dynamics
  1. 2.1 Canine Vaccine Industry Trends
  2. 2.2 Canine Vaccine Industry Drivers
  3. 2.3 Canine Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Vaccine Industry Restraints
3 Canine Vaccine Market by Company
  1. 3.1 Global Canine Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Canine Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Canine Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Canine Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Canine Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Canine Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Canine Vaccine Company Product Type and Application
  8. 3.8 Global Canine Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Canine Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Canine Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Canine Vaccine Market by Type
  1. 4.1 Canine Vaccine Type Introduction
  2. 4.1.1 Core Vaccines
  3. 4.1.2 Non-Core Vaccines
  4. 4.2 Global Canine Vaccine Sales Volume by Type
  5. 4.2.1 Global Canine Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Canine Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Canine Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Canine Vaccine Sales Value by Type
  9. 4.3.1 Global Canine Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Canine Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Canine Vaccine Sales Value Share by Type (2021-2032)
5 Canine Vaccine Market by Application
  1. 5.1 Canine Vaccine Application Introduction
  2. 5.1.1 Puppies
  3. 5.1.2 Adult Dogs
  4. 5.2 Global Canine Vaccine Sales Volume by Application
  5. 5.2.1 Global Canine Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Canine Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Canine Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Canine Vaccine Sales Value by Application
  9. 5.3.1 Global Canine Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Canine Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Canine Vaccine Sales Value Share by Application (2021-2032)
6 Canine Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Canine Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Canine Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Canine Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Canine Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Canine Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Canine Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Canine Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Canine Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Canine Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Canine Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Canine Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Canine Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Canine Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Canine Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Canine Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Canine Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Canine Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Canine Vaccine Sales Value Share by Country, 2025 VS 2032
7 Canine Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Canine Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Canine Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Canine Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Canine Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Canine Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Canine Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Canine Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Canine Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Canine Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Canine Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Canine Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Canine Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Canine Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Canine Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Canine Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Canine Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Canine Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Canine Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Canine Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Canine Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Canine Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Canine Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Canine Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Canine Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Canine Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Canine Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Canine Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Canine Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Canine Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Canine Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Canine Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Canine Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Canine Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Canine Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Canine Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Canine Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Canine Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Canine Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Canine Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogenesis Bago
  2. 8.1.1 Biogenesis Bago Company Information
  3. 8.1.2 Biogenesis Bago Business Overview
  4. 8.1.3 Biogenesis Bago Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
  6. 8.1.5 Biogenesis Bago Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Durvet
  14. 8.3.1 Durvet Company Information
  15. 8.3.2 Durvet Business Overview
  16. 8.3.3 Durvet Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Durvet Canine Vaccine Product Portfolio
  18. 8.3.5 Durvet Recent Developments
  19. 8.4 NeoTech
  20. 8.4.1 NeoTech Company Information
  21. 8.4.2 NeoTech Business Overview
  22. 8.4.3 NeoTech Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 NeoTech Canine Vaccine Product Portfolio
  24. 8.4.5 NeoTech Recent Developments
  25. 8.5 Virbac
  26. 8.5.1 Virbac Company Information
  27. 8.5.2 Virbac Business Overview
  28. 8.5.3 Virbac Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Virbac Canine Vaccine Product Portfolio
  30. 8.5.5 Virbac Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Canine Vaccine Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Jilin Five-Star Animal Health
  38. 8.7.1 Jilin Five-Star Animal Health Company Information
  39. 8.7.2 Jilin Five-Star Animal Health Business Overview
  40. 8.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
  42. 8.7.5 Jilin Five-Star Animal Health Recent Developments
  43. 8.8 JINHE
  44. 8.8.1 JINHE Company Information
  45. 8.8.2 JINHE Business Overview
  46. 8.8.3 JINHE Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 JINHE Canine Vaccine Product Portfolio
  48. 8.8.5 JINHE Recent Developments
  49. 8.9 Wuhan Keqian Biology
  50. 8.9.1 Wuhan Keqian Biology Company Information
  51. 8.9.2 Wuhan Keqian Biology Business Overview
  52. 8.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
  54. 8.9.5 Wuhan Keqian Biology Recent Developments
  55. 8.10 SINOVAC
  56. 8.10.1 SINOVAC Company Information
  57. 8.10.2 SINOVAC Business Overview
  58. 8.10.3 SINOVAC Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 SINOVAC Canine Vaccine Product Portfolio
  60. 8.10.5 SINOVAC Recent Developments
  61. 8.11 Elanco
  62. 8.11.1 Elanco Company Information
  63. 8.11.2 Elanco Business Overview
  64. 8.11.3 Elanco Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Elanco Canine Vaccine Product Portfolio
  66. 8.11.5 Elanco Recent Developments
  67. 8.12 Merck Animal Health
  68. 8.12.1 Merck Animal Health Company Information
  69. 8.12.2 Merck Animal Health Business Overview
  70. 8.12.3 Merck Animal Health Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck Animal Health Canine Vaccine Product Portfolio
  72. 8.12.5 Merck Animal Health Recent Developments
  73. 8.13 RuiPu Bio-Technology
  74. 8.13.1 RuiPu Bio-Technology Company Information
  75. 8.13.2 RuiPu Bio-Technology Business Overview
  76. 8.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
  78. 8.13.5 RuiPu Bio-Technology Recent Developments
  79. 8.14 Zoetis
  80. 8.14.1 Zoetis Company Information
  81. 8.14.2 Zoetis Business Overview
  82. 8.14.3 Zoetis Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Zoetis Canine Vaccine Product Portfolio
  84. 8.14.5 Zoetis Recent Developments
  85. 8.15 CAHIC
  86. 8.15.1 CAHIC Company Information
  87. 8.15.2 CAHIC Business Overview
  88. 8.15.3 CAHIC Canine Vaccine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CAHIC Canine Vaccine Product Portfolio
  90. 8.15.5 CAHIC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Canine Vaccine Value Chain Analysis
  2. 9.1.1 Canine Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Canine Vaccine Sales Mode & Process
  6. 9.2 Canine Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Canine Vaccine Distributors
  9. 9.2.3 Canine Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst